FDA.reportPublic FDA data

BHI Hemorrhoid Tablet

Manufacturer
MediNatura Inc
Effective date
2022-01-05
Label type
HUMAN OTC DRUG LABEL
Version
5
Source
full-release
Hydrated at
2026-06-01 02:15:35

Label at a glance#

ProductBHI Hemorrhoid
Active ingredientHORSE CHESTNUT, ALOE, COLLINSONIA CANADENSIS ROOT, VERONICASTRUM VIRGINICUM ROOT, HYDROCHLORIC ACID, STRYCHNOS NUX-VOMICA SEED, PAEONIA OFFICINALIS ROOT, SULFUR
Label structure8 sections

Indications and uses

For the temporary relief of minor rectal itching, rectal burning, rectal swelling due to hemorrhoids

Dosage and administration

At first sign of symptoms: Adults: 1 tablet every 1/2 to 1 hour until symptoms lessen, then continue with standard dosage. Standard dosage: Adults: Take 1-2 tablets every 4 to 6 hours. Do not exceed 12 tablets in 24 hours. For children under 18, consult your health professional. Allow tablets to dissolve completely in the mouth, do not swallow.

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS

OTC - ACTIVE INGREDIENT SECTION

Each tablet contains: *Aesculus hippocastanum 4X, *Aloe socotrina 4X, *Collinsonia canadensis 4X, *Leptandra virginica 6X, Muriaticum acidum 6X, *Nux vomica 5X, *Paeonia officinalis 6X, *Sulphur 10X 37.5 mg each.

*Natural Ingredients

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Inactive Ingredients: **Dextrose, ** Lactose, Magnesium Stearate, **Maltodextrin
**contains one or more of these ingredients.

PURPOSE

OTC - PURPOSE SECTION

Relieves Hemorrhoid Discomfort

• Rectal Itching

• Rectal Burning

• Swelling

USES

INDICATIONS & USAGE SECTION

For the temporary relief of minor rectal itching, rectal burning, rectal swelling due to hemorrhoids

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

At first sign of symptoms:
Adults: 1 tablet every 1/2 to 1 hour until symptoms lessen,
then continue with standard dosage.
Standard dosage: Adults: Take 1-2 tablets every 4 to 6 hours.
Do not exceed 12 tablets in 24 hours. For children under 18,
consult your health professional.
Allow tablets to dissolve completely in the mouth, do not swallow.

WARNINGS

WARNINGS SECTION

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If condition worsens or does not improve within 7 days, consult a doctor. In case of bleeding, consult a doctor promptly. Do not use if known sensitivity to Hemorrhoid or any of its ingredients exists.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

BHI Hemorrhoid Tablet.jpgBHI Hemorrhoid Tablet.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
62795-1020-3BHI Hemorrhoid100 in 1 BOTTLETABLET1005
62795-1020-3BHI Hemorrhoid1 in 1 CARTONTABLET15

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
62795-1020BHI HEMORRHOID (HORSE CHESTNUT, ALOE, COLLINSONIA CANADENSIS ROOT, VERONICASTRUM VIRGINICUM ROOT, HYDROCHLORIC ACID, STRYCHNOS NUX-VOMICA SEED, PAEONIA OFFICINALIS ROOT, AND SULFUR) TABLET [MEDINATURA INC]5Current NDC, Legacy NDC, 2 package rows20220106_d7df7d3e-48ad-4f58-aef5-a7bd48d2f191.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
62795-1020-2EA - Each62795-1020dce62c0a-1b5f-4bb2-a141-5e36e4abb98c12015-11-12
62795-1020-3EA - Each62795-1020d40c3f22-1981-4854-abc7-a03eac0c4cf512022-12-07

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
ALOEACTIVE INGREDIENTV5VD430YW91
COLLINSONIA CANADENSIS ROOTACTIVE INGREDIENTO2630F3XDR1
HORSE CHESTNUTACTIVE INGREDIENT3C18L6RJAZ1
HYDROCHLORIC ACIDACTIVE INGREDIENTQTT17582CB1
PAEONIA OFFICINALIS ROOTACTIVE INGREDIENT8R564U2E1P1
STRYCHNOS NUX-VOMICA SEEDACTIVE INGREDIENT269XH139191
SULFURACTIVE INGREDIENT70FD1KFU701
VERONICASTRUM VIRGINICUM ROOTACTIVE INGREDIENTM2O62YTN421
ALOEACTIVE MOIETYV5VD430YW91
COLLINSONIA CANADENSIS ROOTACTIVE MOIETYO2630F3XDR1
CULVER'S ROOTACTIVE MOIETYM2O62YTN421
HORSE CHESTNUTACTIVE MOIETY3C18L6RJAZ1
HYDROCHLORIC ACIDACTIVE MOIETYQTT17582CB1
PAEONIA OFFICINALIS ROOTACTIVE MOIETY8R564U2E1P1
STRYCHNOS NUX-VOMICA SEEDACTIVE MOIETY269XH139191
SULFURACTIVE MOIETY70FD1KFU701
LACTOSEINACTIVE INGREDIENTJ2B2A4N98G1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I301

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
62795-102062795-1020-3

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 12 matching rows.

Name, UNII, Kind table
NameUNIIKind
HORSE CHESTNUT3C18L6RJAZACTIB
ALOEV5VD430YW9ACTIB
COLLINSONIA CANADENSIS ROOTO2630F3XDRACTIB
VERONICASTRUM VIRGINICUM ROOTM2O62YTN42ACTIB
HYDROCHLORIC ACIDQTT17582CBACTIB
STRYCHNOS NUX-VOMICA SEED269XH13919ACTIB
PAEONIA OFFICINALIS ROOT8R564U2E1PACTIB
SULFUR70FD1KFU70ACTIB
LACTOSEJ2B2A4N98GIACT
MAGNESIUM STEARATE70097M6I30IACT
MALTODEXTRIN7CVR7L4A2DIACT
DEXTROSEIY9XDZ35W2IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 4 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET / ORAL980 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET / ORAL2500 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET / ORAL980 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET / ORAL2500 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BHI HemorrhoidHORSE CHESTNUT, ALOE, COLLINSONIA CANADENSIS ROOT, VERONICASTRUM VIRGINICUM ROOT, HYDROCHLORIC ACID, STRYCHNOS NUX-VOMICA SEED, PAEONIA OFFICINALIS ROOT, AND SULFURMediNatura Incd7df7d3e-48ad-4f58-aef5-a7bd48d2f1912022-01-05WarningsExact identifier
ndc (package): 62795-1020-3
ndc (product): 62795-1020
ndc11 (package): 62795102003
spl id: 6647c7d7-3d0e-44f1-bc4b-9ec8fed27a14
spl set id: d7df7d3e-48ad-4f58-aef5-a7bd48d2f191

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.